Category: Latest News
-
CeriBell Shares Gain After Medicare Approves Additional Payment for Delirium Monitoring System
CeriBell Inc. (NASDAQ:CBLL) shares climbed about 3% after the company announced that the U.S. Centers for Medicare & Medicaid Services (CMS) approved a New Technology Add-on Payment (NTAP) for its Delirium Monitor System. Medicare to Provide Additional Reimbursement Under the NTAP approval, hospitals may receive up to $2,171 in additional reimbursement for each eligible Medicare…
-
Twist Bioscience Shares Decline Following Quarterly Earnings Miss
Twist Bioscience (NASDAQ:TWST) shares fell 4.2% in pre-market trading after the synthetic biology company reported fiscal third-quarter results that exceeded revenue expectations but fell short of Wall Street’s earnings forecast. The mixed performance prompted investors to focus on the company’s continued profitability challenges despite solid top-line growth. Revenue Beats Expectations, but Earnings Disappoint Twist Bioscience…
-
FDA Awards Breakthrough Therapy Designation to Lilly’s Olomorasib for Pancreatic Cancer
Eli Lilly and Company (NYSE:LLY) has received Breakthrough Therapy designation from the U.S. Food and Drug Administration for its investigational drug olomorasib as a standalone treatment for adults with advanced pancreatic cancer carrying a KRAS G12C mutation who have previously received at least one systemic therapy. The designation is intended to accelerate the development and…
-
Nexera Technologies Pursues Exclusive Distribution Rights for Darknet Intelligence Platform
Nexera Technologies Ltd. (NASDAQ:NEXR) has entered into a letter of intent with Nebo Holdings Limited that could see the company become the exclusive global reseller and distributor of Preempt OSINT, a cybersecurity platform designed to monitor darknet activity. The proposed partnership would expand Nexera’s cybersecurity offering by giving it exclusive rights to commercialize the platform…
-
Sportradar Shares Drop After Earnings Miss and Lower-Than-Expected Outlook
Sportradar Group AG (NASDAQ:SRAD) reported second-quarter 2026 results on Monday that fell short of analyst expectations on both earnings and revenue, while its full-year guidance also disappointed investors. The sports technology company’s shares declined 13.20% in pre-market trading following the earnings release. Earnings and Revenue Miss Wall Street Forecasts Sportradar reported adjusted earnings of €0.00…
-
Krystal Biotech Shares Slide Despite Earnings Beat as Revenue Misses Forecasts
Krystal Biotech, Inc. (NASDAQ:KRYS) reported second-quarter 2026 results on Monday that exceeded earnings expectations but fell short of Wall Street’s revenue estimates, sending the stock down 7.65% in pre-market trading. Earnings Outperform While Revenue Comes in Below Expectations The company reported adjusted earnings of $1.79 per share for the second quarter, beating analysts’ consensus estimate…
-
Supernus Shares Jump After Revenue Beat, Higher Guidance and Indivior Merger Announcement
Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) reported second-quarter 2026 results on Monday that fell short of earnings expectations but exceeded revenue forecasts, while also announcing a merger agreement with Indivior Pharmaceuticals (NASDAQ:INDV). The combination of stronger sales, improved guidance and the proposed transaction sent Supernus shares up 18.75% in pre-market trading. Revenue Tops Expectations Despite Earnings Loss…
-
Sally Beauty Shares Slip After Revenue Miss Overshadows Earnings Beat
Sally Beauty Holdings Inc. (NYSE:SBH) reported fiscal third-quarter 2026 results on Monday that exceeded earnings expectations but fell short of Wall Street’s revenue forecast, sending the stock 3.14% lower in pre-market trading. Earnings Beat Estimates While Revenue Falls Short For the quarter ended June 30, 2026, Sally Beauty posted adjusted diluted earnings of $0.55 per…
-
Integer Shares Gain After Earnings Beat and KKR Buyout Announcement
Integer Holdings Corporation (NYSE:ITGR) reported second-quarter 2026 results on Monday that came in ahead of analyst expectations, while also announcing a definitive agreement to be acquired by KKR in an all-cash transaction. The medical device outsourcing specialist saw its shares rise 2.43% in pre-market trading following the earnings release and acquisition announcement. Earnings and Revenue…
-
Marriott Shares Slip Despite Earnings Beat as Revenue Falls Short of Expectations
Marriott International Inc. (NASDAQ:MAR) reported second-quarter results before Monday’s market open that topped earnings forecasts but missed Wall Street’s revenue expectations, sending the hotel operator’s shares down 3.4% in pre-market trading. Earnings Outperform While Revenue Misses Estimates Marriott posted adjusted earnings of $3.19 per share for the quarter, exceeding analysts’ consensus estimate of $3.05 by…